Cell Bio Human Tech Co.,Ltd Stock: price and insider trades · South Korea
셀바이오휴먼텍
No insider purchase over the last 90 days. The latest, by 이권선, was filed 12 Jun 2026.
Cell Bio Human Tech Co.,Ltd: what insiders have been doing
Cell Bio Human Tech Co.,Ltd, classified in the Food & Beverage sector, is a listed company. Its insiders report their share dealings to DART (FSS). The last twelve months, up to 1 November 2026, brought 15 filings signed by 8 insiders.
Only purchases show up on the open market, 14 purchases in all worth €63k, filed by 7 insiders. The amount is not disclosed for 11 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Among those who bought: 3 board members, 3 senior executives and 1 major shareholder. The largest single trade was a purchase of €26k by 이권선, published on 30 March 2026, equal to 0.084% of the market capitalisation.
With 15 filings in twelve months, the company is more active than the median of 7 filings across the 2,655 companies we follow on the same exchange. Since 2023, the database holds 44 purchases and no sales by insiders of the company.
The last purchase on record was published on 12 June 2026, which is 150 days ago. Filings reach the DART (FSS) feed a median of 6 days after the trade. Until a filing is published, the market cannot know about the trade.
Elsewhere in the same sector, our signals recently picked up insider purchases at Davide Campari - Milano N.V. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySale+1 other insider
Since the insiders bought
- -9.4%Entry ₩6,730 · Close 30 Oct 2026 ₩6,100
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 139,134 sharesKRXDART:20260612000695Canonical exit: 10 Sept 2026 (T+90)
- 12,403 sharesShareKRXDART:20260520000152Canonical exit: 18 Aug 2026 (T+90)
- 7,053 sharesShareKRXDART:20260520000151Canonical exit: 18 Aug 2026 (T+90)
- 5,553 shares@ ₩7,057.99240.072% mcap35.3% of flowShareKRXDART:20260407003480Canonical exit: 30 Jun 2026 (T+90)
- 6,400 shares@ ₩7,138.34380.084% mcap41.4% of flowShareKRXDART:20260330001675Canonical exit: 23 Jun 2026 (T+90)
- ●Executives0DART
- 3,800 shares@ ₩6,602.57890.047% mcap23.2% of flowShareKRXDART:20260312000364Canonical exit: 8 Jun 2026 (T+90)
- 55,818 sharesKRXDART:20260107000616Canonical exit: 30 Mar 2026 (T+90)
- 5,379 sharesShareKRXDART:20260107000289Canonical exit: 7 Apr 2026 (T+90)
- 1,378 sharesShareKRXDART:20260106000211Canonical exit: 6 Apr 2026 (T+90)
- 5,404 sharesShareKRXDART:20260105000075Canonical exit: 5 Apr 2026 (T+90)
- 837 sharesShareKRXDART:20260105000360Canonical exit: 5 Apr 2026 (T+90)
- 6,888 sharesShareKRXDART:20260105000280Canonical exit: 5 Apr 2026 (T+90)
- 22,234 sharesShareKRXDART:20260105000430Canonical exit: 5 Apr 2026 (T+90)
- 1,154 sharesShareKRXDART:20260105000052Canonical exit: 5 Apr 2026 (T+90)
- 2,475 sharesShareKRXDART:20250527000180Canonical exit: 25 Aug 2025 (T+90)
- 10,666 sharesShareKRXDART:20250312000231Canonical exit: 10 Jun 2025 (T+90)
- 5,289 sharesShareKRXDART:20250210000266Canonical exit: 11 May 2025 (T+90)
- 1,000 sharesShareKRXDART:20241230000132Canonical exit: 30 Mar 2025 (T+90)
- 3,320 sharesShareKRXDART:20241216000375Canonical exit: 16 Mar 2025 (T+90)
- ShareKRXDART:20241216000360Canonical exit: 11 Mar 2025 (T+90)
- 4,075 sharesShareKRXDART:20241210000513Canonical exit: 10 Mar 2025 (T+90)
- 26,055 sharesShareKRXDART:20241122000291Canonical exit: 20 Feb 2025 (T+90)
- 11,767 sharesKRXDART:20241122000281Canonical exit: 16 Feb 2025 (T+90)
- ShareKRXDART:20240829001022Canonical exit: 24 Nov 2024 (T+90)
25 of 45 declarations
About Cell Bio Human Tech Co.,Ltd
Selbio Human Tech is a company operating in the food sector, listed on the XKRX market. It specializes in developing innovative solutions for the food industry.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
